Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Gynecologic 1 Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 44 Specimen Handling 38 enzalutamide 30 Nivolumab 30 pembrolizumab 28 Docetaxel 23 Gemcitabine 22 apalutamide 20 Prednisone 20 Biopsy 20 Abiraterone Acetate 18 Androgen Antagonists 17 cabozantinib 14 darolutamide 13 abiraterone 13 Radiotherapy 13 Cisplatin 12 enfortumab vedotin 11 Radiation 11 Ipilimumab 11 Pluvicto 10 erdafitinib 9 belzutifan 9 atezolizumab 9 X-Rays 9 Radiosurgery 9 Mitomycin 9 olaparib 8 cabazitaxel 8 Standard of Care 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

RC48 antibody × Genitourinary × 30 days × Clear all

NCT07608224 2026-05-27

HOPE-07-MIBC

West China Hospital

Phase 2/3 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡